533 related articles for article (PubMed ID: 34481638)
1. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
2. Transgender men: clinical care and implications in reproductive medicine: introduction.
de Ziegler D; de Sutter P
Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
[TBL] [Abstract][Full Text] [Related]
3. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
[TBL] [Abstract][Full Text] [Related]
4. The uterus in transgender men.
Carbonnel M; Karpel L; Cordier B; Pirtea P; Ayoubi JM
Fertil Steril; 2021 Oct; 116(4):931-935. PubMed ID: 34364678
[TBL] [Abstract][Full Text] [Related]
5. Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know.
Patel DP; Goodwin IA; Acar O; Kocjancic E; Hotaling JM
Fertil Steril; 2021 Oct; 116(4):924-930. PubMed ID: 34404544
[TBL] [Abstract][Full Text] [Related]
6. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
Stoffers IE; de Vries MC; Hannema SE
J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
[TBL] [Abstract][Full Text] [Related]
7. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.
Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F
Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072
[TBL] [Abstract][Full Text] [Related]
8. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
[TBL] [Abstract][Full Text] [Related]
10. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
11. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
[TBL] [Abstract][Full Text] [Related]
12. Endocrinology of Transgender Medicine.
T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
[TBL] [Abstract][Full Text] [Related]
13. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
14. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
Ford K; Huggins E; Sheean P
J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
16. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
[TBL] [Abstract][Full Text] [Related]
17. Gender-Affirming Hormone Therapy for Transgender Men.
Moravek MB
Clin Obstet Gynecol; 2018 Dec; 61(4):687-704. PubMed ID: 30285972
[TBL] [Abstract][Full Text] [Related]
18. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
19. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
20. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
